Created with Highcharts 11.1.0Apr '24Jul '24Oct '24Jan '255.000.234

Profile

Edit
LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets. It is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.
URL https://www.lianbio.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Biotechnology
Next Earnings Release Jan. 22, 2025 (est.)
Last Earnings Release Nov. 13, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Mar. 15, 2024

Profile

Edit
LianBio is a science-driven biopharmaceutical company dedicated to developing and commercializing medicines for patients with unmet medical needs, with an initial focus on in-licensing assets for Greater China and other Asian markets. It is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.
URL https://www.lianbio.com
Investor Relations URL N/A
HQ State/Province New Jersey
Sector Health Care
Industry Biotechnology
Next Earnings Release Jan. 22, 2025 (est.)
Last Earnings Release Nov. 13, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Mar. 15, 2024
Quickflows